Literature DB >> 24649307

Downregulation of expression of transporters associated with antigen processing 1 and 2 and human leukocyte antigen I and its effect on immunity in nasopharyngeal carcinoma patients.

Yan-Xin Ren1, Jie Yang1, Li-Juan Zhang2, Rui-Mei Sun1, Liu-Fang Zhao1, Ming Zhang3, Yun Chen2, Jing Ma4, Kun Qiao1, Qiang-Ming Sun5, Hai-Ting Long5, Yun-Chao Huang6, Xiao-Jiang Li1.   

Abstract

The human leukocyte antigen (HLA)-I and antigen-processing machinery (APM) are crucial in the anti-cancer immune response. The aim of this study was to assess the clinical significance of the APM components [transporters associated with antigen processing (TAP)-1 and -2 and HLA-I] in nasopharyngeal carcinoma (NPC). A total of 58 NPC specimens and 20 healthy specimens used as control were evaluated by semiquantitative immunohistochemistry for three APM components (TAP-1, TAP-2 and HLA-I). The expression of the APM components in NPC was downregulated. CD4+ and CD8+ T cells were measured by flow cytometry and IL-10 was measured by ELISA. The number of CD8+ T cells and the expression of IL-10 were higher and the number of CD4+ T cells was lower in NPC, compared to the controls. The number of CD8+ T cells and the expression of IL-10 were negatively correlated with TAP-1, TAP-2 and HLA-I expression. The clinical phase, lymph node metastasis, distant metastasis, pathological type, TAP-1 expression, TAP-2 expression and HLA-I expression were identified as prognostic factors by the Kaplan-Meier analysis. A multivariate analysis using a Cox regression model indicated that distant metastasis and the downregulation of HLA-I expression were independent unfavorable prognostic factors. In conclusion, the lower expression of HLA-I induced immunosuppression in NPC patients and was associated with a poor prognosis.

Entities:  

Keywords:  human leucocyte antigen I; nasopharyngeal neoplasms; transporter associated with antigen processing 1; transporter associated with antigen processing 2

Year:  2013        PMID: 24649307      PMCID: PMC3916213          DOI: 10.3892/mco.2013.194

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  28 in total

Review 1.  Familial and large-scale case-control studies identify genes associated with nasopharyngeal carcinoma.

Authors:  Jin-Xin Bei; Wei-Hua Jia; Yi-Xin Zeng
Journal:  Semin Cancer Biol       Date:  2012-02-01       Impact factor: 15.707

Review 2.  Non-viral environmental risk factors for nasopharyngeal carcinoma: a systematic review.

Authors:  Wei-Hua Jia; Hai-De Qin
Journal:  Semin Cancer Biol       Date:  2012-01-30       Impact factor: 15.707

3.  Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumors.

Authors:  Angelica Facoetti; Rosanna Nano; Paola Zelini; Patrizia Morbini; Eugenio Benericetti; Mauro Ceroni; Michael Campoli; Soldano Ferrone
Journal:  Clin Cancer Res       Date:  2005-12-01       Impact factor: 12.531

4.  Comparison of Epstein-Barr virus DNA level in plasma, peripheral blood cell and tumor tissue in nasopharyngeal carcinoma.

Authors:  Jian-Yong Shao; Yu Zhang; Yu-Hong Li; Hong-Yi Gao; Hui-Xia Feng; Qiu-Liang Wu; Nian-Ji Cui; Gang Cheng; Bin Hu; Li-Fu Hu; Ingemar Ernberg; Yi-Xin Zeng
Journal:  Anticancer Res       Date:  2004 Nov-Dec       Impact factor: 2.480

5.  A single-nucleotide deletion leads to rapid degradation of TAP-1 mRNA in a melanoma cell line.

Authors:  Tianyu Yang; Beth A McNally; Soldano Ferrone; Yang Liu; Pan Zheng
Journal:  J Biol Chem       Date:  2003-02-11       Impact factor: 5.157

6.  Down-regulation of HLA class I antigen in human papillomavirus type 16 E7 expressing HaCaT cells: correlate with TAP-1 expression.

Authors:  Wei Li; Xiao-Mei Deng; Chuan-Xin Wang; Xiao Zhang; Gui-Xi Zheng; Jian Zhang; Jin-Bo Feng
Journal:  Int J Gynecol Cancer       Date:  2010-02       Impact factor: 3.437

7.  Characterization of human lymphocyte antigen class I antigen-processing machinery defects in renal cell carcinoma lesions with special emphasis on transporter-associated with antigen-processing down-regulation.

Authors:  Barbara Seliger; Derek Atkins; Michaela Bock; Ulrike Ritz; Soldano Ferrone; Christoph Huber; Stefan Störkel
Journal:  Clin Cancer Res       Date:  2003-05       Impact factor: 12.531

8.  Reduced expression of tocopherol-associated protein (TAP/Sec14L2) in human breast cancer.

Authors:  Xi Wang; Jing Ni; Chen-Long Hsu; Sharlin Johnykutty; Ping Tang; Yuan-Soon Ho; Chia-Hwa Lee; Shuyuang Yeh
Journal:  Cancer Invest       Date:  2009-12       Impact factor: 2.176

9.  Priming of immune responses against transporter associated with antigen processing (TAP)-deficient tumours: tumour direct priming.

Authors:  Xiao-Lin Li; Dongqing Zhang; David Knight; Yoshinobu Odaka; Jonathan Glass; J Michael Mathis; Qian-Jin Zhang
Journal:  Immunology       Date:  2009-11       Impact factor: 7.397

10.  HLA class I antigen processing machinery component expression and intratumoral T-Cell infiltrate as independent prognostic markers in ovarian carcinoma.

Authors:  Liz Y Han; Mavis S Fletcher; Diana L Urbauer; Peter Mueller; Charles N Landen; Aparna A Kamat; Yvonne G Lin; William M Merritt; Whitney A Spannuth; Michael T Deavers; Koen De Geest; David M Gershenson; Susan K Lutgendorf; Soldano Ferrone; Anil K Sood
Journal:  Clin Cancer Res       Date:  2008-06-01       Impact factor: 12.531

View more
  5 in total

Review 1.  Current status and advances of immunotherapy in nasopharyngeal carcinoma.

Authors:  Jian-Ying Xu; Xiao-Li Wei; Yi-Qin Wang; Feng-Hua Wang
Journal:  Ther Adv Med Oncol       Date:  2022-05-07       Impact factor: 5.485

2.  Viral IL-10 down-regulates the "MHC-I antigen processing operon" through the NF-κB signaling pathway in nasopharyngeal carcinoma cells.

Authors:  Yan-Xin Ren; Jie Yang; Rui-Mei Sun; Li-Juan Zhang; Liu-Fang Zhao; Bao-Zhong Li; Lei Li; Hai-Ting Long; Qiang-Ming Sun; Yun-Chao Huang; Xiao-Jiang Li
Journal:  Cytotechnology       Date:  2016-09-20       Impact factor: 2.058

Review 3.  The Microenvironment in Epstein-Barr Virus-Associated Malignancies.

Authors:  Geok Wee Tan; Lydia Visser; Lu Ping Tan; Anke van den Berg; Arjan Diepstra
Journal:  Pathogens       Date:  2018-04-13

Review 4.  The Global Landscape of EBV-Associated Tumors.

Authors:  Claire Shannon-Lowe; Alan Rickinson
Journal:  Front Oncol       Date:  2019-08-06       Impact factor: 6.244

5.  EBNA2 driven enhancer switching at the CIITA-DEXI locus suppresses HLA class II gene expression during EBV infection of B-lymphocytes.

Authors:  Chenhe Su; Fang Lu; Samantha S Soldan; R Jason Lamontagne; Hsin-Yao Tang; Giorgia Napoletani; Paul J Farrell; Italo Tempera; Andrew V Kossenkov; Paul M Lieberman
Journal:  PLoS Pathog       Date:  2021-08-05       Impact factor: 7.464

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.